• facebook
  • twitter
  • youtube



【演題】 Translational research on pancreatic β-cells for the treatment of diabetes

【講師】 Jun Shirakawa, MD, PhD

【所属】 Professor, Laboratory of Diabetes and Metabolic Disorders, Institute for Molecular and Cellular Regulation (IMCR), Gunma University

【日時】 令和5年8月25日(金)16:00ー18:00

【場所】 健康医科学イノベーション棟105室 

The decline in β-cell mass due to the failure of β-cell compensation or the β-cell death is one cause of the development of both type 1 and type 2 diabetes. Therefore, elucidation of the mechanism by which an adaptive increase in β-cell mass through interorgan networks occurs in vivo will lead to the development of a cure for diabetes. The immune system is an emerging target as an important player in regulating β-cell function and mass. A remaining barrier for the treatment of human diabetes using β-cells is the differences between human and rodent islets. In this seminar, I will focus on the crosstalks between islets and other tissues that regulate adaptive β-cell proliferation for the treatment of diabetes considering the abovementioned issues.


問合せ先: 医学医療系・免疫学
渋谷 彰(ashibuya@md.tsukuba.ac.jp